Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis

Table 1 Correlations between circMET and clinicopathological features in 209 HCC

variables	circMET high	circMET low	P value
Age (years)
≥ 52	33	60	0.168
< 52	38	78	0.168
Sex
Male	66	113	0.031
Female	5	25	0.031
Liver cirrhosis
Yes	63	124	< 0.802
No	8	14	< 0.802
HBsAg
Positive	62	111	0.212
Negative	9	27	0.212
Tumor size (diameter, cm)
≤ 5	35	82	0.163
> 5	36	56	0.163
Tumor number
Multiple	17	17	0.031
Single	54	121	0.031
Microvascular invasion
Yes	28	36	0.047
No	43	102	0.047
Tumor encapsulation
Yes	27	75	0.025
No	44	63	0.025
HCC stage
Ia	27	81	0.020
Ib	31	44
IIa	12	13
IIb	1	0

ISSN: 1476-4598